Schulze et al. also described the detection of EPCAM-positive CTCs in hepatocellular carcinoma patients (HCC) and found that these cells were detected more frequently in patients with intermediate or advanced HCC than in those with local limited disease; accordingly, their presence was associated with poor overall survival [60]. Here, EPCAM is linked to hepatocellular carcinoma.